Understanding how a specific molecule affects inflammation in Alzheimer's disease
Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease
This study is looking at how a protein called JAM-A affects inflammation in Alzheimer's disease by examining how certain white blood cells behave, with the hope of finding new ways to reduce inflammation and support brain health for people with Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11087579 on NIH RePORTER |
What this research studies
This research investigates the role of junctional adhesion molecule-A (JAM-A) in the inflammatory response associated with Alzheimer's disease (AD). It focuses on how neutrophils, a type of white blood cell, contribute to inflammation in both the brain and blood, potentially leading to cognitive decline. By manipulating JAM-A and observing its effects on neutrophil behavior in a mouse model of AD, the study aims to uncover mechanisms that could help reduce inflammation and improve brain health. The findings could provide insights into new therapeutic strategies for managing Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it, particularly those experiencing cognitive decline.
Not a fit: Patients with other forms of dementia or neurological conditions unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce inflammation in the brains of Alzheimer's patients, potentially slowing disease progression and improving cognitive function.
How similar studies have performed: Other research has shown promising results in targeting inflammatory processes in Alzheimer's disease, suggesting that this approach could be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Andjelkovic-Zochowska, Anuska V. — University of Michigan at Ann Arbor
- Study coordinator: Andjelkovic-Zochowska, Anuska V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.